A blood test that quantifies the protein ACE2, the cellular protein that allows entry of the coronavirus into cells, as well as ACE2 fragments produced as a result of interaction with the virus, could be a simple and effective ...
Jul 13, 2021
0
3
Researchers at the Francis Crick Institute have identified a protein that helps tumors evade the immune system and, in certain types of cancers, is linked to a poorer chance of survival. The protein could become a target ...
Jun 2, 2021
0
13
Scientists have found clues that the world's leading COVID-19 vaccines offer lasting protection that could diminish the need for frequent booster shots, but they caution that more research is needed and that virus mutations ...
Jun 2, 2021
0
12
Months after recovering from mild cases of COVID-19, people still have immune cells in their body pumping out antibodies against the virus that causes COVID-19, according to a study from researchers at Washington University ...
May 24, 2021
2
2692
A preclinical study has found multiple myeloma is highly sensitive to a newly developed experimental therapy, according to research published today by Peter Mac scientists.
May 21, 2021
0
41
Canadian immunologists have identified a mechanism that promotes the activation of T cell receptors by altering how one of its components interacts with the cell membrane.
South Australian researchers are hoping to improve the outcome of patients with multiple myeloma after identifying a new protein associated with the most aggressive form of the disease.
Mar 9, 2021
0
4
The goal of the COVID-19 vaccines being rolled out worldwide is to stimulate our immune systems into creating a protective response against the coronavirus, particularly by generating antibodies. These antibodies then circulate ...
Feb 18, 2021
0
6
A study published in Nature Communications today presents a compelling new evidence about what a key protein called alpha-synuclein actually does in neurons in the brain.
Feb 10, 2021
0
124
Rituximab, an anti-cancer drug targeting the membrane protein CD20, was the first approved therapeutic antibody against B tumor cells. Immunologists at the University of Freiburg have now solved a mystery about how it works. ...
Feb 10, 2021
0
141
